XML 37 R37.htm IDEA: XBRL DOCUMENT v3.20.1
Stockholders' Equity (Tables)
9 Months Ended
Mar. 31, 2020
Stockholders Equity  
Summary of Option Activity

 

   Number of Shares
Underlying
Outstanding
Options
  Weighted
Average
Remaining
Contractual
Life (Years)
  Weighted
Average
Exercise
Price
  Intrinsic
Value
Options outstanding as of June 30, 2019   4,050,000    2.3 years   $.02   $13,500 
Granted   300,000    4.4 years    .03    —   
Exercised   —      —      —      —   
Forfeited or expired   (350,000)   

1.3 years

    .03    —   
Options outstanding as of March 31, 2020   4,000,000    

1.8 years

    .02   $110,700 
Options exercisable as of March 31, 2020   2,950,000    

1.3 years

    .02   $90,400 

Assumptions

 

   Nine Months 
Ended March 31, 2020
  Nine Months 
Ended March 31, 2019
Exercise Price:   $.02 - $.03    $.038 - $.046 
Volatility:   405% - 407%    380% - 391% 
Risk Free Rate:   1.6% - 1.81%    2.3% - 2.7% 
Vesting Period:   4 years    4 years 
Forfeiture Rate:   0%   0%
Expected Life   4.1 years    4.1 years 
Dividend Rate   0%   0%

Outstanding stock options

 

    Outstanding Options   Exercisable Options
Exercise Prices   Number
of Shares
  Remaining
Life 
(Years)
  Weighted
Average 
Price
  Number of
Shares
  Weighted
Average
 Price
    .01 to .03       3,800,000       1.7     $ .02       2,900,000     $ .02
    $ .034 to .05      

200,000

     

3.3

   

$

.05

     

50,000

   

$

.05

Total stock options       4,000,000       1.8     $ .02       2,950,000     $ .02

Stock option compensation expense

 

   Three Months 
Ended March 31,
  Nine Months 
Ended March 31,
   2020  2019  2020  2019
   (in thousands)
Cost of Goods Sold  $—     $—     $—     $—   
Other Selling and Marketing   1    1    12    3 
General and Administrative   3    4    3    14 
Total Stock-based Compensation Expense  $4   $5   $15   $17 

Common Stock for issuance

 

   March 31,
   2020
Shares of common stock reserved for issuance under the 2015 Stock Option Plan   5,000,000 
Shares of common stock issuable upon conversion of the Preferred Stock   4,300,000 
Total shares of common stock equivalents   9,300,000